Literature DB >> 4299224

The therapeutic application of diazoxide in pediatric hypoglycemic states.

A Drash, F Kenny, J Field, R Blizzard, H Langs, F Wolff.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4299224     DOI: 10.1111/j.1749-6632.1968.tb19059.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  7 in total

1.  Effects of fetal exposure to diazoxide in man.

Authors:  R D Milner; S K Chouksey
Journal:  Arch Dis Child       Date:  1972-08       Impact factor: 3.791

2.  Islet-cell tumour causing hypoglycaemia in a newborn infant.

Authors:  D B Grant; P R Barbor
Journal:  Arch Dis Child       Date:  1970-06       Impact factor: 3.791

3.  Dangers of diazoxide.

Authors:  B H Boeree
Journal:  Br Med J       Date:  1973-02-17

4.  Late Presentation of Fulminant Necrotizing Enterocolitis in a Child with Hyperinsulinism on Octreotide Therapy.

Authors:  Colin Patrick Hawkes; N Scott Adzick; Andrew A Palladino; Diva D De León
Journal:  Horm Res Paediatr       Date:  2016-02-12       Impact factor: 2.852

5.  Dominant form of congenital hyperinsulinism maps to HK1 region on 10q.

Authors:  Sara E Pinney; Karthik Ganapathy; Jonathan Bradfield; David Stokes; Ariella Sasson; Katarzyna Mackiewicz; Kara Boodhansingh; Nkecha Hughes; Susan Becker; Stephanie Givler; Courtney Macmullen; Dimitrios Monos; Arupa Ganguly; Hakon Hakonarson; Charles A Stanley
Journal:  Horm Res Paediatr       Date:  2013-07-13       Impact factor: 2.852

6.  [Leucine sensitive hypoglycemia. Follow-up studies under treatment with diazoxide (author's transl)].

Authors:  T Lücking
Journal:  Eur J Pediatr       Date:  1976-03-08       Impact factor: 3.183

7.  Efficacy and safety of diazoxide for treating hyperinsulinemic hypoglycemia: A systematic review and meta-analysis.

Authors:  Xiaohong Chen; Lifang Feng; Hui Yao; Luhong Yang; Yuan Qin
Journal:  PLoS One       Date:  2021-02-11       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.